Related Experiment Video

Updated: Jan 14, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.2K

Newer Drugs for Tuberculosis Prevention and Treatment in Children

Ben J Marais1

  • 1The Children's Hospital at Westmead and the Marie Bashir Institute for Infectious Diseases and Biosecurity (MBI), University of Sydney, Sydney, Australia. ben.marais@health.nsw.gov.au.

Indian Journal of Pediatrics
|February 2, 2019
PubMed

Insights

Childhood tuberculosis (TB) in India faces significant prevention and treatment hurdles. This overview explores newer drugs for latent TB infection (LTBI) and multidrug-resistant TB (MDR-TB) in children.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Childhood tuberculosis (TB) presents a substantial, often underestimated, health burden in endemic nations like India.
  • Despite improved data visibility, establishing effective TB prevention and treatment programs for children remains difficult.
  • Key barriers include guideline non-implementation, diagnostic uncertainties, and limited guidance on managing drug-resistant TB contacts and pediatric cases.

Purpose of the Study:

  • To review current challenges in childhood TB prevention and treatment in India.
  • To present an overview of novel pharmacological options for TB prevention and treatment in pediatric populations.
  • To discuss new drugs for latent TB infection (LTBI) and multidrug-resistant TB (MDR-TB) in children.

Main Methods:

  • Literature review of recent advancements in pediatric TB management.
  • Analysis of barriers to TB prevention and treatment programs for children.
  • Discussion of newer drugs and repurposed agents for LTBI and MDR-TB in children.

Main Results:

  • Identified significant barriers in implementing TB guidelines and managing drug-resistant TB in children.
  • Highlighted diagnostic challenges and poor integration with maternal and child health services.
  • Presented an overview of emerging drugs and treatment strategies for pediatric TB, including LTBI and MDR-TB.

Conclusions:

  • Newer drugs offer promising options for TB prevention and treatment in children, particularly for LTBI and MDR-TB.
  • Addressing implementation barriers and improving healthcare system linkages are crucial for effective childhood TB control.
  • This information aims to support clinical decision-making pending updated WHO guidelines for pediatric TB management.

Keywords:
Latent tuberculosis infectionPreventionTherapyTreatmentTuberculosis

More Related Videos

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.0K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.3K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
209
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
533
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
473
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
822
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
924